|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 19, 2019 ) "Market Overview
A brain tumor occurs when abnormal cells from within the brain. There are two major types of tumors, malignant or cancerous tumors and benign tumors. Increasing incidence of the brain tumor is one of the major factors which is driving the growth of the market globally. As per the Central Brain Tumor Registry of the United States report 2016, an estimated 79,270 new cases of primary malignant, nonmalignant are anticipated to be diagnosed in the US in 2017 (26,070 primary malignant and 53,200 nonmalignant). The rising prevalence of brain cancer cases across the globe is expected to drive the demand of the brain tumor therapeutics market over the forecast period. The high cost of cancer therapy is one of the major factors restraining the growth of the market studied. The treatment for brain tumor differs depending on several factors, such as age, general health, and the size, location, and type of tumor. Furthermore, there are some adverse effects of the treatments that are restraining the growth of the market studied, over the forecast period.
Scope of the Report
Brain tumor arises from abnormal growth of cancerous cells in the brain. A brain tumor is one of the leading causes of death, globally. Meningioma is the most common kind of brain tumor and the hardest to treat, while, treatments for glioma usually have better outcomes.
Request a sample of Brain Tumor Therapeutics Market report @ http://www.arcognizance.com/enquiry-sample/454209
Key Market Trends
Immunotherapy Segment is Expected to Register Robust Growth
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Vaccines are a promising new form of immunotherapy that stimulates the immune system to fight cancer. The use of immunotherapy in glioblastoma multiforme which is the most common primary malignant brain tumor in adults has been found to be effective. In 2018, a European trial succeeded in proving the feasibility and efficacy of treating brain cancer with personalized immunotherapy tailored for each patient. This phase I/II trial that runs across six European centers, tested a combination of two personalized vaccines in patients with glioblastoma. These clinical trials are expected to drive the market studied.
The United States is Expected to Retain Largest Market Share During the Period of Forecast.
The US dominates the brain tumor treatment market in North America. The US is anticipated to lead the market owing to the developed healthcare industry coupled with rising awareness regarding advanced technologies amongst the population in this region. In the United States, the incidence of all primary malignant and non-malignant brain and other CNS tumors is 22.36 cases per 100,000, for a total count of 368,117 tumor incidences. Meningioma is the most common form of brain tumor, followed by Gliomas. Eflornithine is designated as an orphan drug in the United States and received Breakthrough Therapy Designation in the country for the treatment of anaplastic Glioma
Access this report of Brain Tumor Therapeutics Market @ http://arcognizance.com/report/brain-tumor-therapeutics-market-growth-trends-and-forecast-2019-2024
Competitive Landscape
The market for brain tumor therapeutics is highly concentrated with a few global players controlling a significant share of the market. Key players in the market include Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis AG, and Pfizer Inc. among others.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
Buy The Report @ http://www.arcognizance.com/purchase/454209
Major Point of TOC:
Chapter One: INTRODUCTION
Chapter Two: RESEARCH METHODOLOGY
Chapter Three: EXECUTIVE SUMMARY
Chapter Four: MARKET DYNAMICS
Chapter Five: MARKET SEGMENTATION
Chapter Six: COMPETITIVE LANDSCAPE
Chapter Seven: MARKET OPPORTUNITIES AND FUTURE TRENDS
Request a sample of Brain Tumor Therapeutics Market report @ http://www.arcognizance.com/enquiry-sample/454209
About Us:
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics""based on the data collection facilities of big data, the face of ""business research facilities"" has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the ""out of the box""developments in the market.
Contact US:
Name: Analytical research cognizance
Address: 100 Church Street,
8th floor, Manhattan,
New York 10007
Phone: +1 (646) 434-7969 +91 90967 44448
Email: enquiry@arcognizance.com
Follows to Twitter : https://twitter.com/ARCognizance
Follows to Linkdin : https://www.linkedin.com/company/arcognizance"
Analytical Research Cognizance
Avanti dengale
+91 90967 44448
avanti.dengale@arcognizance.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
